Damora Therapeutics Inc (DMRA) Price Prediction & ForecastDMRADamora Therapeutics Inc

Alphio's DMRA stock price prediction model matches the current Damora Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $21.46 (-0.12%). The 1-week path is $21.82 (+1.55%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Damora Therapeutics (DMRA) is a good buy right now, trading at $21.09 with an RSI of 59.68, indicating bullish momentum. Analysts project a price target of $60, suggesting a potential upside of 184% from the current price. The recent 5-day price change of +14.37% shows positive short-term momentum, while the company has a solid cash position of $532.9 million to fund operations through 2029. However, the main risk is the negative earnings trend, with an EPS estimate of -0.52 for the next quarter, indicating ongoing losses.

Damora Therapeutics Inc (DMRA) last closed at $21.4899998, losing -2.36%. These facts feed the 1-day and 1-week DMRA price prediction above.